Simplicity of randomized, controlled trials of percutaneous vertebraplasty

Pain Physician

Volumn 6, Issue 3, 2003, Pages 342-343

  Hirsch, Joshua A ^a   Do, Huy M ^b   Kallmes, David ^c   Ruedy, Richard M ^d   Jarvik, Jeffrey G ^e  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MAYO CLINIC   (United States)

^d Regulatory Affairs   (United States)

^e UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NARCOTIC ANALGESIC AGENT; PLACEBO;

CLINICAL PRACTICE; DRUG USE; FOOD AND DRUG ADMINISTRATION; HUMAN; MOVEMENT (PHYSIOLOGY); NOTE; OUTCOMES RESEARCH; PAIN; PERCUTANEOUS VERTEBROPLASTY; PRACTICE GUIDELINE; SURGICAL TECHNIQUE; VERTEBRA FRACTURE;

EID: 0042063596     PISSN: 15333159     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (5)

1. Jarvik, JG, Deyo, RA. Cementing the evidence: time for a randomized trial of vertebroplasty. AJNR 2000; 21:1373-1374
2. Burton AW, Mendel E. Vertebroplasty and kyphoplasty: a review. Pain Physician 2003;
3. Kallmes DF, Jensen ME, Marx WF, et al. A pilot study for a sham-controlled, randomized, prospective, crossover trial of percutaneous vertebroplasty, RSNA 2002.
4. Do HM; Marcellus ML, Weir RU, et aL Percutaneous vertebroplasty versus medical therapy for treatment of acute vertebral body compression fractures: a prospective randomized study. RSNA, 2002.
5. Parallax Medical, Inc., press release: FDA Approves Randomized Clinical Trial of Vertebroplasty Products by Parallax Medical, Inc., December 3, 2002, Chicago, IL.